New York State Common Retirement Fund’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-82,791
| Closed | -$5.62M | – | 3246 |
|
|
2019
Q3 | $5.62M | Sell |
82,791
-10,400
| -11% | -$714K | 0.01% | 1186 |
|
|
2019
Q2 | $5.42M | Buy |
93,191
+9,707
| +12% | +$575K | 0.01% | 1225 |
|
|
2019
Q1 | $5.85M | Buy |
83,484
+53,134
| +175% | +$3.94M | 0.01% | 1181 |
|
|
2018
Q4 | $1.96M | Buy |
30,350
+6,790
| +29% | +$476K | ﹤0.01% | 1567 |
|
|
2018
Q3 | $1.65M | Sell |
23,560
-1,540
| -6% | -$90.1K | ﹤0.01% | 1801 |
|
|
2018
Q2 | $1.26M | Buy |
25,100
+2,200
| +10% | +$87.3K | ﹤0.01% | 1970 |
|
|
2018
Q1 | $717K | Hold |
22,900
| – | – | ﹤0.01% | 2195 |
|
|
2017
Q4 | $783K | Hold |
22,900
| – | – | ﹤0.01% | 2160 |
|
|
2017
Q3 | $735K | Buy |
22,900
+2,000
| +10% | +$63.1K | ﹤0.01% | 2175 |
|
|
2017
Q2 | $680K | Sell |
20,900
-1
| -0% | -$32 | ﹤0.01% | 2253 |
|
|
2017
Q1 | $658K | Buy |
20,901
+1
| +0% | +$30 | ﹤0.01% | 2247 |
|
|
2016
Q4 | $614K | Hold |
20,900
| – | – | ﹤0.01% | 2281 |
|
|
2016
Q3 | $604K | Buy |
20,900
+3,500
| +20% | +$97.5K | ﹤0.01% | 2222 |
|
|
2016
Q2 | $451K | Hold |
17,400
| – | – | ﹤0.01% | 2314 |
|
|
2016
Q1 | $431K | Hold |
17,400
| – | – | ﹤0.01% | 2315 |
|
|
2015
Q4 | $612K | Hold |
17,400
| – | – | ﹤0.01% | 2214 |
|
|
2015
Q3 | $368K | Sell |
17,400
-941
| -5% | -$24.2K | ﹤0.01% | 2461 |
|
|
2015
Q2 | $510K | Buy |
+18,341
| New | +$517K | ﹤0.01% | 2512 |
|
|
2013
Q4 | – | Sell |
-16,840
| Closed | -$515K | – | 1977 |
|
|
2013
Q3 | $515K | Hold |
16,840
| – | – | ﹤0.01% | 1855 |
|
|
2013
Q2 | $534K | Buy |
+16,840
| New | +$553K | ﹤0.01% | 1725 |
|
New York State Common Retirement Fund's GHDX Position: Q4 2019 in Review
New York State Common Retirement Fund sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 82,791 shares — an estimated $5.62M sold.
New York State Common Retirement Fund first reported a position in GHDX in Q2 2013 and held it in 20 quarters. The position peaked at $5.85M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- New York State Common Retirement Fund reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- New York State Common Retirement Fund sold 82,791 Genomic Health, Inc. shares in Q4 2019, an estimated $5.62M.
- New York State Common Retirement Fund first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 20 quarters.
- New York State Common Retirement Fund's Genomic Health, Inc. position peaked at $5.85M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on New York State Common Retirement Fund's 13F filing for Q4 2019, filed 5 Feb 2020.